Trastorno de identidad de género. Parte II: terapia endocrinológica en el proceso de readecuación corporal
Devoto C., Enzo; Ríos S., Rafael; Aravena C., Lucía.
Rev. chil. endocrinol. diabetes
; 9(2): 58-64, 2016. tab
Artículo en Español | LILACS | ID: biblio-831347
Documentos relacionados
[Adolescents with gender identity disorder: reconsideration of the age limits for endocrine treatment and surgery].
Hormonal therapy and sex reassignment: a systematic review and meta-analysis of quality of life and psychosocial outcomes.
Replacement Hormone Therapy for Gender Dysphoria and Congenital Sexual Anomalies.
Bone health and body composition in transgender adults before gender-affirming hormonal therapy: data from the COMET study.
Gender Affirming Medical Treatment Desire and Treatment Motives in Binary and Non-Binary Transgender Individuals.
Changing trends in transgender demographics and morbidity: baseline data from a Spanish cohort.
Sexual functioning in patients with major depressive disorder in randomized placebo-controlled studies of extended release quetiapine fumarate.
Evaluation of Renal Function in Transgender Patients After Gender-Affirming Hormone Therapy.
Cross-sex hormone therapy for gender dysphoria.
The metabolic effects of hormonal treatment in transgender males: Safety of the testosterone gender-affirming therapy.